{
    "2021-12-10": [
        [
            {
                "time": "2022-01-05",
                "original_text": "UPDATE 2-Drugmakers aim big price hikes at U.S. patients, congressional report finds",
                "features": {
                    "keywords": [
                        "Drugmakers",
                        "price hikes",
                        "U.S.",
                        "patients",
                        "congressional report"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2022-01-06",
                "original_text": "Eli Lilly Pens $1.5B Pact With Regor For Metabolic Disease Therapies",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Regor",
                        "Metabolic Disease",
                        "Therapies",
                        "$1.5B"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-01-07",
                "original_text": "Drugmakers aim big price hikes at U.S. patients, congressional report finds",
                "features": {
                    "keywords": [
                        "Drugmakers",
                        "price hikes",
                        "U.S.",
                        "patients",
                        "congressional report"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2022-01-08",
                "original_text": "Drugmakers aim big price hikes at U.S. patients -congressional report",
                "features": {
                    "keywords": [
                        "Drugmakers",
                        "price hikes",
                        "U.S.",
                        "patients",
                        "congressional report"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2022-01-09",
                "original_text": "Pharma Stock Roundup: PFE Booster Works on Omicron, AZN COVID Cocktail Gets FDA Nod",
                "features": {
                    "keywords": [
                        "PFE",
                        "Booster",
                        "Omicron",
                        "AZN",
                        "FDA",
                        "Cocktail"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-01-10",
                "original_text": "Lilly and Regor Therapeutics Group Enter into Strategic Collaboration to Discover and Develop Novel Therapies for Metabolic Disorders",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Regor",
                        "Strategic Collaboration",
                        "Metabolic Disorders",
                        "Novel Therapies"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}